$3.34
00.00%
Last update: 4:00 PM
15 minutes delayed
Comments
Loading...
Poseida Therapeutics
PSTXNASDAQ
Poseida Therapeutics (NASDAQ:PSTX) Stock, Insider Trading Activity
Poseida Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Poseida Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Poseida Therapeutics Inc
Institutional Shares Held
30.008M
Institutional Percentage Held
30.9%
| Aug 10, 2022 | Malin Life Sciences Holdings Ltd | 10% OWNER | 2.15M | $3.50 | $7.53M | BUY | 22.20% | 11.84M | Aug 08 | View |
| Aug 10, 2022 | Eric Ostertag | EXECUTIVE CHAIRMAN | 142.86K | $3.50 | $500.00K | BUY | 8.62% | 1.80M | Aug 08 | View |
| Aug 05, 2022 | Eric Ostertag | EXECUTIVE CHAIRMAN | -160.70K | $3.69 | -$592.81K | SELL | -14.32% | 961.45K | Aug 03 | View |
| Mar 18, 2022 | Kerry Ingalls | CHIEF OPERATING OFFICER | 3.00K | $3.98 | $11.94K | BUY | 5.77% | 55.00K | Mar 16 | View |
| Dec 07, 2021 | Malin Life Sciences Holdings Ltd | 10% OWNER | 1.83K | $6.90 | $12.61K | BUY | 0.02% | 9.69M | Dec 06 | View |
| Dec 02, 2021 | Malin Life Sciences Holdings Ltd | 10% OWNER | 51.25K | $6.85 | $351.19K | BUY | 0.53% | 9.68M | Nov 30 - Dec 02 | View |
| Nov 29, 2021 | Malin Life Sciences Holdings Ltd | 10% OWNER | 39.36K | $6.83 | $268.96K | BUY | 0.41% | 9.63M | Nov 24 - Nov 29 | View |
| Nov 23, 2021 | Malin Life Sciences Holdings Ltd | 10% OWNER | 25.73K | $7.06 | $181.64K | BUY | 0.27% | 9.59M | Nov 19 - Nov 23 | View |
| Nov 18, 2021 | Kerry Ingalls | CHIEF OPERATING OFFICER | 2.00K | $7.00 | $14.00K | BUY | ∞ | 2.00K | Nov 17 | View |
| Nov 18, 2021 | Malin Life Sciences Holdings Ltd | 10% OWNER | 379.38K | $7.20 | $2.73M | BUY | 4.13% | 9.57M | Nov 16 - Nov 18 | View |
| Nov 10, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -18.92K | $7.09 | -$134.17K | SELL | -0.53% | 3.52M | Nov 08 | View |
| Oct 05, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -20.03K | $7.02 | -$140.60K | SELL | -0.56% | 3.53M | Oct 01 | View |
| Sep 22, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -20.00K | $8.00 | -$160.02K | SELL | -1.75% | 1.12M | Sep 20 | View |
| Sep 15, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | 1.28K | $8.13 | $10.02K | SELL-OPTIONS | 0.11% | 1.14M | Sep 13 - Sep 14 | View |
| Sep 03, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -112.41K | $8.39 | -$943.65K | SELL | -3.05% | 3.58M | Sep 01 - Sep 02 | View |
| Aug 24, 2021 | Matthew Spear | CHIEF MEDICAL OFFICER | 0.00 | $5.05 | -$29.85K | SELL-OPTIONS | 0.00% | 41.48K | Aug 20 | View |
| Aug 04, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -33.67K | $8.05 | -$270.97K | SELL | -0.92% | 3.63M | Aug 02 - Aug 03 | View |
| Jul 06, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -48.10K | $9.28 | -$446.17K | SELL | -1.30% | 3.65M | Jul 01 - Jul 02 | View |
| Jun 14, 2021 | Matthew Spear | CHIEF MEDICAL OFFICER | 0.00 | $5.38 | -$32.46K | SELL-OPTIONS | 0.00% | 16.48K | Jun 11 | View |
| Jun 03, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -81.92K | $8.48 | -$694.30K | SELL | -2.18% | 3.67M | Jun 01 - Jun 02 | View |
| May 05, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -54.31K | $8.63 | -$468.84K | SELL | -1.44% | 3.71M | May 03 - May 04 | View |
| Apr 23, 2021 | Matthew Spear | CHIEF MEDICAL OFFICER | 5.00K | $4.88 | -$21.85K | SELL-OPTIONS | 43.54% | 16.48K | Apr 21 - Apr 23 | View |
| Apr 05, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -115.00K | $9.61 | -$1.10M | SELL | -2.99% | 3.73M | Apr 01 - Apr 05 | View |
| Mar 03, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -115.00K | $11.60 | -$1.33M | SELL | -2.94% | 3.79M | Mar 01 - Mar 02 | View |
| Feb 17, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -133.15K | $10.00 | -$1.33M | SELL | -10.28% | 1.16M | Feb 16 | View |
| Feb 12, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | 55.15K | $5.64 | -$36.77K | SELL-OPTIONS | 4.45% | 1.30M | Feb 10 | View |
| Jan 25, 2021 | Eric Ostertag | CHIEF EXECUTIVE OFFICER | -4.46K | $10.00 | -$44.62K | SELL | -0.34% | 1.31M | Jan 21 | View |
| Jul 15, 2020 | Sean Murphy | — | 9.20M | $16.00 | $160.00K | DERIVATIVE CONVERSION | ∞ | 10.00K | Jul 14 | View |
| Jul 15, 2020 | David Hirsch | DIRECTOR | 2.71M | $16.00 | $4.00M | BUY | ∞ | 2.71M | Jul 14 | View |
| Jul 15, 2020 | Bland Marcea Lloyd | — | 10.00K | $16.00 | $160.00K | PURCHASE | ∞ | 10.00K | Jul 14 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.